Cortexyme, Inc. Gains 39.5%
Fri, Dec 20, 2019 at 06:48 PM
Cortexyme, Inc. (CRTX:NASDAQ) jumped higher at $66.08, representing a gain of 39.5%. On Thu 19 Dec 19, CRTX:NASDAQ hit a New 2-Week High of $47.37. The stock got featured on our News Catalysts scanner on Mon 09 Dec 19 at 11:54 AM in the 'IPO' category. From Fri 29 Nov 19, the stock recorded 85.71% Up Days and 86.67% Green Days
About Cortexyme, Inc. (CRTX:NASDAQ)
Cortexyme Inc is a clinical stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases. Its approach is based on the seminal discovery of the presence of Porphyromonas gingivalis, or P. gingivalis, and its secreted toxic virulence factor proteases, called gingipains.
Top 10 Gainers:
- DropCar, Inc. (DCAR:NASDAQ), 106.9%
- LAIX Inc. (LAIX:NYSE), 85.51%
- Marinus Pharmaceuticals, Inc. (MRNS:NASDAQ), 44.67%
- Cortexyme, Inc. (CRTX:NASDAQ), 39.5%
- China Online Education Group (COE:NYSE), 37.36%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 29.73%
- Barnwell Industries, Inc. (BRN:NYSEMKT), 28.57%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 26.75%
- iBio, Inc. (IBIO:NYSEMKT), 25.58%